Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

A LAG-3-Specific Agonist Antibody for the Treatment of T Cell-Induced Autoimmune Diseases.

Angin M, Brignone C, Triebel F.

J Immunol. 2020 Jan 6. pii: ji1900823. doi: 10.4049/jimmunol.1900823. [Epub ahead of print]

PMID:
31907283
2.

Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.

Donadini MP, Dentali F, Pegoraro S, Pomero F, Brignone C, Guasti L, Steidl L, Ageno W.

Vasc Med. 2017 Dec;22(6):518-524. doi: 10.1177/1358863X17720531. Epub 2017 Jul 21.

PMID:
28732457
3.

Hepatic brucelloma.

Barutta L, Ferrigno D, Melchio R, Borretta V, Bracco C, Brignone C, Giraudo A, Serraino C, Baralis E, Grosso M, Fenoglio LM.

Lancet Infect Dis. 2013 Nov;13(11):987-93. doi: 10.1016/S1473-3099(13)70197-X. Review.

PMID:
24156899
4.

Venous lower-limb evaluation in patients with acute pulmonary embolism.

Pomero F, Brignone C, Serraino C, Panzone S, Bracco C, Migliore E, Dalmasso P, Perin PC, Fenoglio LM.

South Med J. 2011 Jun;104(6):405-11. doi: 10.1097/SMJ.0b013e318213d037.

PMID:
21886029
5.

MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.

Hemon P, Jean-Louis F, Ramgolam K, Brignone C, Viguier M, Bachelez H, Triebel F, Charron D, Aoudjit F, Al-Daccak R, Michel L.

J Immunol. 2011 May 1;186(9):5173-83. doi: 10.4049/jimmunol.1002050. Epub 2011 Mar 25.

6.

Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates.

Poirier N, Haudebourg T, Brignone C, Dilek N, Hervouet J, Minault D, Coulon F, de Silly RV, Triebel F, Blancho G, Vanhove B.

Clin Exp Immunol. 2011 May;164(2):265-74. doi: 10.1111/j.1365-2249.2011.04329.x. Epub 2011 Feb 24.

7.

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity.

Brignone C, Gutierrez M, Mefti F, Brain E, Jarcau R, Cvitkovic F, Bousetta N, Medioni J, Gligorov J, Grygar C, Marcu M, Triebel F.

J Transl Med. 2010 Jul 23;8:71. doi: 10.1186/1479-5876-8-71.

8.

Early stratification of patients with chest pain and suspected acute coronary syndrome in the Emergency Department.

Bracco C, Melchio R, Sturlese U, Pomero F, Martini G, Poggi A, Cena P, Severini S, Castagna E, Brignone C, Serraino C, Dutto L, Veglio F, Fenoglio L.

Minerva Med. 2010 Apr;101(2):73-80.

PMID:
20467407
9.

A phase I pharmacokinetic and biological correlative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma.

Brignone C, Escudier B, Grygar C, Marcu M, Triebel F.

Clin Cancer Res. 2009 Oct 1;15(19):6225-31. doi: 10.1158/1078-0432.CCR-09-0068. Epub 2009 Sep 15.

10.

Primary hepatic carcinoid: a case report and literature review.

Fenoglio LM, Severini S, Ferrigno D, Gollè G, Serraino C, Bracco C, Castagna E, Brignone C, Pomero F, Migliore E, David E, Salizzoni M.

World J Gastroenterol. 2009 May 21;15(19):2418-22. Review.

11.

Pasteurella multocida infection in a cirrhotic patient: case report, microbiological aspects and a review of literature.

Migliore E, Serraino C, Brignone C, Ferrigno D, Cardellicchio A, Pomero F, Castagna E, Osenda M, Fenoglio L.

Adv Med Sci. 2009;54(1):109-12. doi: 10.2478/v10039-009-0005-8. Review.

PMID:
19366651
12.

Vertebroplasty in the treatment of osteoporosis vertebral fractures: report on 52 cases.

Fenoglio L, Cena P, Migliore E, Bracco C, Ferrigno D, Silvestri A, Lingua G, Gollè G, Brignone C, Serraino C, Gallarato G, Pomero F, Grosso M.

J Endocrinol Invest. 2008 Sep;31(9):795-8.

PMID:
18997492
13.

A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells.

Brignone C, Grygar C, Marcu M, Schäkel K, Triebel F.

J Immunol. 2007 Sep 15;179(6):4202-11.

14.

IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: a single-blind phase I study.

Brignone C, Grygar C, Marcu M, Perrin G, Triebel F.

Vaccine. 2007 Jun 11;25(24):4641-50. Epub 2007 Apr 24.

PMID:
17493710
15.
16.

hHR23B is required for genotoxic-specific activation of p53 and apoptosis.

Kaur M, Pop M, Shi D, Brignone C, Grossman SR.

Oncogene. 2007 Feb 22;26(8):1231-7. Epub 2006 Aug 21.

17.

A soluble LAG-3 protein as an immunopotentiator for therapeutic vaccines: Preclinical evaluation of IMP321.

Fougeray S, Brignone C, Triebel F.

Vaccine. 2006 Jun 29;24(26):5426-33. Epub 2006 Mar 31.

PMID:
16621192
18.

Yin Yang 1 is a negative regulator of p53.

Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, Shi Y.

Cell. 2004 Jun 25;117(7):859-72.

19.

A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.

Brignone C, Bradley KE, Kisselev AF, Grossman SR.

Oncogene. 2004 May 20;23(23):4121-9.

PMID:
15064742
20.

Recruitment of the actin-binding protein HIP-55 to the immunological synapse regulates T cell receptor signaling and endocytosis.

Le Bras S, Foucault I, Foussat A, Brignone C, Acuto O, Deckert M.

J Biol Chem. 2004 Apr 9;279(15):15550-60. Epub 2004 Jan 16.

21.

Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions.

Roger PM, Durant J, Ticchioni M, Halfon P, Breittmayer JP, Brignone C, Chaillou S, Dunais B, Dellamonica P, Bernard A; Groupe D'Etudes Nicois Polyvalent En Infectiologie.

J Antimicrob Chemother. 2003 Aug;52(2):269-75. Epub 2003 Jul 1.

PMID:
12837745
22.

Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM.

Science. 2003 Apr 11;300(5617):342-4.

23.

Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation.

Roger PM, Breittmayer JP, Durant J, Sanderson F, Ceppi C, Brignone C, Cua E, Clevenbergh P, Fuzibet JG, Pesce A, Bernard A, Dellamonica P; Groupe d'Etudes Niçois Polyvalent en Infectiologie.

J Infect Dis. 2002 Feb 15;185(4):463-70. Epub 2002 Jan 31.

PMID:
11865398
24.

Proteases produced by activated neutrophils are able to release soluble CD23 fragments endowed with proinflammatory effects.

Brignone C, Munoz O, Batoz M, Rouquette-Jazdanian A, Cousin JL.

FASEB J. 2001 Sep;15(11):2027-9. Epub 2001 Jul 24.

PMID:
11511513
26.

Favourable, significant effect of the dose-dependent treatment with RU 38486 (RU) on the alterations of the hepatic mitochondrial function of diabetic rats.

Brignone JA, de Brignone CM, Ricci CR, de Mignone IR, Susemihl MC, Rodríguez RR.

Diabetes Res Clin Pract. 1996 May;32(3):141-8.

PMID:
8858202
27.

Preparation of pig pure islets without using density gradients.

Abalovich A, Mignone I, Susemihl C, Ricci C, Migliore S, Rodriguez R, Brignone C, Brignone J.

Transplant Proc. 1995 Dec;27(6):3353. No abstract available.

PMID:
8539990
28.

Effects of thyroid hormones on mitochondrial oxygen consumption in brown adipose tissue and heart from cold-exposed hypothyroid rats.

Cageao LF, Mignone IR, Ricci CR, Brignone CC, Brignone JA, Zaninovich AA.

Acta Endocrinol (Copenh). 1992 Jul;127(1):72-5.

PMID:
1519427
29.

Improving effects obtained by the ovariectomy or treatment with tamoxifen of female diabetic rats over the function and enzyme activities of liver mitochondria.

Brignone JA, de Brignone CM, de Mignone IR, Ricci CR, Susemihl MC, Rodríguez RR.

Horm Metab Res. 1991 Feb;23(2):56-61.

PMID:
1646149
30.

[Effects of cold on myocardial mitochondria respiration of rats with hypothyroidism treated with triiodothyronine].

Cageao LF, de Mignone IR, Ricci CR, de Brignone CM, Altschuler LR, Brignone JA, Zaninovich AA.

Medicina (B Aires). 1991;51(4):331-4. Spanish.

PMID:
1821921
31.

Effect of ovarian hormones upon liver mitochondrial function in diabetic rats.

Brignone JA, de Brignone CM, Rodríguez RR, Marzi AA, de Mignone IR, Susemihl MC.

Diabetes Res Clin Pract. 1988 Apr 6;4(4):247-56.

PMID:
3371176
32.

Modulation of D-3-hydroxybutyrate dehydrogenase activity by estrogens.

Brignone JA, Ricci CR, de Brignone CM, Labonia NA, Stoppani AO.

Biochem Int. 1987 Apr;14(4):605-16.

PMID:
3453087
33.

[Hepatotoxic effect of 2 anovulatory steroids, mestranol and norethisterone acetate in the rat].

Brignone JA, De Brignone CM, De Dávila MT, Koch O, Stoppani AO.

Medicina (B Aires). 1979 Jul-Aug;39(4):477-88. Spanish. No abstract available.

PMID:
161795
34.

[Changes in liver mitochondria in rat after treatment with oral contraceptives].

Brignone JA, de Brignone CM, Gamboni M, Koch O, Stoppani AO.

Medicina (B Aires). 1978 Jul-Aug;38(4):413-21. Spanish. No abstract available.

PMID:
739878
35.

[Effect of diethylstilbestrol on phospholipid metabolism in liver mitochondria and microsomes].

Brignone JA, de Brignone CM, Stoppani AO.

C R Seances Soc Biol Fil. 1971;165(4):969. French. No abstract available.

PMID:
4259523
36.

[Effect of diethylstilbestrol on the metabolism of liver mitochondrial and microsomal phospholipids].

Brignone JA, De Brignone CM, Stoppani AO.

Rev Soc Argent Biol. 1970 Aug-Nov;46(5):152-8. Spanish. No abstract available.

PMID:
5527106
37.

[Action of estrogens on myocardial and kidney NADH2-oxidase systems].

de Brignone CM, Stoppani AO, Brignone JA.

C R Seances Soc Biol Fil. 1969 Apr 3;162(10):1851-2. French. No abstract available.

PMID:
4305789
38.

[Action of gestational hormones and corticoids on myocardial respiratory systems].

de Brignone CM, Stoppani AO, Brignone JA.

C R Seances Soc Biol Fil. 1969 Apr 3;162(10):1845. French. No abstract available.

PMID:
4305788
39.

Structural requirements for the action of steroids as inhibitors of electron transfer.

Stoppani AO, De Brignone CM, Brignone JA.

Arch Biochem Biophys. 1968 Sep 20;127(1):463-75. No abstract available.

PMID:
4301565
40.

[Changes in the metabolism of mitochondrial phospholipids induced by synthetic estrogens].

Brignone JA, De Brignone CM, Stoppani AO.

Rev Soc Argent Biol. 1968 Aug-Nov;44(5):156-62. Spanish. No abstract available.

PMID:
5744868
41.

[In vivo action of synthetic estrogens on the NADH2-oxidase system in rat organs].

Brignone JA, de Brignone CM, Stoppani AO.

C R Seances Soc Biol Fil. 1968;162(8):1621-2. French. No abstract available.

PMID:
4238202
42.

[Action of androgens on the electron transport systems in the myocardium].

de Brignone CM, Stoppani AO, Brignone JA.

C R Seances Soc Biol Fil. 1968;162(8):1616-7. French. No abstract available.

PMID:
4238197
43.

[Action of estrogens on the NADH2-oxidase systems of the myocardium and kidney].

De Brignone CM, Stoppani AO, Brignone JA.

Rev Soc Argent Biol. 1967 Apr-Jul;43(1):65-73. Spanish. No abstract available.

PMID:
5600382
44.

[Action of gestagens and corticoids on the respiratory systems of the myocardium].

De Brignone CC, Stoppani AO, Brignone JA.

Rev Soc Argent Biol. 1967 Apr-Jul;43(1):29-39. Spanish. No abstract available.

PMID:
5600377
45.

[Action of stilbestrol and analogues on the NADH 2-oxidase system of the rat prostate].

Brignone JA, De Brignone CM, Stoppani AO.

Rev Soc Argent Biol. 1966 Aug-Nov;42(5):208-13. Spanish. No abstract available.

PMID:
5987606
46.

[Action in vivo of artificial estrogens on the NADH 2-oxidase system of rat organs].

Brignone JA, De Brignone CM, Stoppani AO.

Rev Soc Argent Biol. 1966 Aug-Nov;42(5):191-8. Spanish. No abstract available.

PMID:
5987604
47.

[Action of androgens on respiratory systems of myocardium].

De Brignone CM, Stoppani AO, Brignone JA.

Rev Soc Argent Biol. 1966 Aug-Nov;42(5):153-66. Spanish. No abstract available.

PMID:
5987601
48.

[Action of steroid hormones on the NADH2-oxidase system in rats in vivo].

Brignone JA, De Brignone CC, Stoppani AO.

Rev Soc Argent Biol. 1964 Aug-Nov;40(5):135-40. Spanish. No abstract available.

PMID:
5890587

Supplemental Content

Loading ...
Support Center